Health Care: Drugs

Anika Therapeutics Inc (ANIK: NASDAQ)

$39.17 -0.45 | -1.14%
04/20/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 105.59M 75.08M 71.36M 64.78M
Cost of Sales 16.22M 17.99M 24.46M 22.78M
Gross Operating Profit 89.37M 57.09M 46.90M 42.00M
Selling, General, and Administrative Expenses 15.07M 12.94M 14.73M 17.86M
Research & Development 8.14M 7.06M 5.39M 6.17M
Operating Income before D & A (EBITDA) 66.15M 37.09M 26.78M 17.97M
Depreciation & Amortization 4.71M 4.77M 4.53M 4.00M
Interest Income 58.14K 0.00 0.00 0.00
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 286.84K 0.00 0.00
Total Income Before Interest Expenses (EBIT) 61.51M 32.61M 19.72M 13.97M
Interest Expense 0.00 127.19K 187.78K 182.39K
Pre-Tax Income 61.51M 32.48M 19.53M 13.79M
Income Taxes 23.19M 11.91M 7.77M 5.32M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 38.32M 20.57M 11.76M 8.47M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 38.32M 20.57M 11.76M 8.47M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 38.32M 20.57M 11.76M 8.47M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
38.32M 20.29M 14.30M 8.47M
Preferred Dividends
Net Income Available To Common 38.32M 20.57M 11.76M 8.47M
Basic EPS from Continuing Ops. 2.61 1.46 0.89 0.65
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.61 1.46 0.89 0.65
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.61 1.46 0.89 0.65
Basic Normalized Net Income/Share 2.61 1.44 1.08 0.65
EPS fr Continuing Ops. 2.51 1.39 0.82 0.62
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.51 1.39 0.82 0.62
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.51 1.39 0.82 0.62
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.51 1.37 1.00 0.62
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ANIK

Latest ANIK Headlines from TheStreet

More Financial News for ANIK

Press Releases for ANIK

See All Press Releases

Partner Headlines for ANIK

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter